PTSD: Symptoms, Brain Changes, Treatment & Self-Assessment

Months after the accident, you still freeze at the sound of screeching brakes. You wake at 3 a.m. from the same dream, heart slamming against your ribs. During the day you avoid that stretch of road, but the images still ambush you without warning. You start wondering whether something is wrong with you.

Nothing is wrong with you. What you are experiencing has a name: post-traumatic stress disorder (PTSD). Epidemiological studies estimate that roughly 6% to 8% of the general population will meet criteria for PTSD at some point in their lives, with rates climbing to 10% to 30% among individuals exposed to combat, sexual violence, or major disasters. Many people wait years before seeking help, assuming the distress will fade on its own.

This article walks through PTSD from a clinical psychiatry perspective: what happens inside the brain, which symptoms define the condition, what treatments have the strongest evidence behind them, and where you can start with self-screening.

What Is PTSD?

PTSD is a condition in which the brain's threat detection system remains locked in a state of high alert long after a traumatic event has ended. The DSM-5 requires that the person was directly exposed to, witnessed, learned about (involving a close family member or friend), or was repeatedly exposed to aversive details of a traumatic event^[1].

Common traumatic events include motor vehicle accidents, natural disasters, combat, sexual assault, childhood abuse, and witnessing death. The critical factor is not the objective severity of the event but the subjective impact on the individual. Two people involved in the same car crash may respond very differently: one recovers within weeks, while the other remains trapped in the memory for months.

At its core, PTSD reflects a failure of the brain to properly file a traumatic memory as something that happened in the past. Instead, the memory stays in an active, unprocessed state, continually triggering the body's survival responses as though the danger is still present.

Symptoms typically emerge within three months of the trauma, although delayed onset (appearing months or even years later) is well documented. A diagnosis requires that symptoms persist for more than one month and cause significant impairment in daily functioning.

What Happens in the Brain

PTSD is not merely a psychological reaction. Neuroimaging research has identified measurable changes in both brain structure and function among individuals with the condition^[2].

Amygdala hyperactivation. The amygdala serves as the brain's threat alarm. In PTSD, it responds to potential danger cues with far greater intensity than normal, firing even in objectively safe environments. This is why a sound, a smell, or a fleeting image can catapult a person back into the traumatic moment within seconds.

Prefrontal cortex hypoactivation. The prefrontal cortex normally acts as a brake on the amygdala, helping you evaluate a threat signal rationally and conclude that you are safe. In PTSD, prefrontal activity is reduced, which means the alarm keeps ringing with no one to turn it off. The result is emotional overwhelm, exaggerated startle, and difficulty calming down once triggered.

Hippocampal volume reduction. The hippocampus is responsible for sorting and storing memories in context. Studies consistently find that individuals with PTSD have smaller hippocampal volumes compared to matched controls^[2]. A compromised hippocampus struggles to tag a memory as "something that already ended," leaving traumatic memories in a state that feels perpetually current.

Neurotransmitter dysregulation. Norepinephrine levels remain chronically elevated, keeping the body in a sustained fight-or-flight posture. Cortisol regulation through the HPA axis is disrupted, losing its normal negative feedback loop. Serotonin and endocannabinoid systems are also affected, contributing to low mood, emotional numbness, and reduced capacity for pleasure.

The Four Symptom Clusters of PTSD

DSM-5 organizes PTSD symptoms into four clusters. A diagnosis requires at least one symptom from each cluster^[1]:

The four symptom clusters of PTSD

In my clinic, patients often describe it in two ways. Some say, "I can manage during the day, but the moment things get quiet, my brain replays the scene on a loop I cannot stop." Others tell me, "I have become a completely different person. I used to love going out. Now I do not want to go anywhere, and nothing holds my interest." Both descriptions point to core features of PTSD.

Treatment

PTSD is a treatable condition. International guidelines, including the 2023 VA/DoD Clinical Practice Guideline^[3] and the NICE guidelines, place trauma-focused psychotherapy as the first-line treatment, with medication as an adjunct or alternative.

Psychotherapy: Three First-Line Approaches

Prolonged Exposure (PE). Developed by Edna Foa, PE guides patients through repeated, structured retelling of the traumatic memory in a safe therapeutic setting, combined with gradual real-world exposure to avoided situations. Through this process, the brain learns that recalling the memory, while painful, does not actually recreate the danger, and the fear response diminishes over time.

Cognitive Processing Therapy (CPT). CPT focuses on the distorted beliefs that form after trauma, such as "It was entirely my fault" or "The world is never safe." The therapist helps the patient identify these "stuck points" and, through structured writing assignments and Socratic questioning, develop more balanced and realistic beliefs.

Eye Movement Desensitization and Reprocessing (EMDR). During EMDR sessions, the patient recalls the traumatic image while following the therapist's finger moving side to side (bilateral stimulation). Research shows that EMDR is as effective as PE and CPT in reducing PTSD symptoms^[4]. The exact mechanism remains under investigation, but the prevailing hypothesis is that bilateral stimulation helps the brain reprocess and integrate the traumatic memory.

All three therapies have demonstrated consistent efficacy in randomized controlled trials, and all are recommended as first-line psychological treatments by international guidelines^[3]. A full course typically involves 8 to 16 sessions, each lasting 60 to 90 minutes.

Medication

Only two medications carry FDA approval specifically for PTSD: sertraline (Zoloft) and paroxetine (Paxil)^[5]. Both are SSRIs that work by increasing serotonin availability in the synapse, reducing the frequency of intrusive memories and the intensity of emotional responses.

Venlafaxine (Effexor), an SNRI, does not hold an FDA indication for PTSD but has shown efficacy in multiple randomized controlled trials and is considered a reasonable alternative in international guidelines.

For patients whose primary complaint is nightmares, prazosin (Minipress) deserves special mention. Originally an antihypertensive, prazosin is an alpha-1 adrenergic receptor antagonist that has been shown to significantly reduce trauma-related nightmares and improve sleep quality^[6]. In my clinical experience, adding prazosin often produces a noticeable improvement in sleep within the first week or two.

Medications commonly used for PTSD

Repetitive Transcranial Magnetic Stimulation (rTMS)

rTMS is a noninvasive brain stimulation technique that uses magnetic pulses delivered through the scalp to modulate neural activity in targeted brain regions. Emerging research suggests that stimulation of the right dorsolateral prefrontal cortex (right DLPFC) may provide additional benefit for individuals with treatment-resistant PTSD^[7].

The current level of evidence is classified as "probably effective" (Level B), and rTMS is not yet a standard first-line treatment for PTSD. However, for patients who have not responded adequately to medication and psychotherapy, it offers a reasonable option worth discussing with your clinician. A typical course consists of daily sessions over two to four weeks.

Self-Screening: The PC-PTSD-5

If you suspect you may have PTSD, a brief validated screener can help you decide whether to seek a professional evaluation. The PC-PTSD-5 is a five-item questionnaire developed by the U.S. National Center for PTSD^[8], designed for rapid screening in primary care settings.

It asks: In the past month, have you...

1. Had nightmares about the event or thought about it when you did not want to?
2. Tried hard not to think about it, or gone out of your way to avoid situations that reminded you of it?
3. Been constantly on guard, watchful, or easily startled?
4. Felt numb or detached from people, activities, or your surroundings?
5. Felt guilty or unable to stop blaming yourself or others for the event or any problems it may have caused?

A score of 3 or higher (out of 5) suggests further clinical evaluation is warranted. The screener is not a diagnostic tool, but it has strong sensitivity for detecting probable PTSD. You can find the full instrument on the VA National Center for PTSD website: PC-PTSD-5.

When to Seek Help

Consider scheduling an appointment with a psychiatrist or mental health professional if you notice any of the following after a traumatic experience:

• Symptoms have persisted for more than one month with no sign of improvement
• Nightmares or flashbacks are significantly disrupting your sleep or daytime concentration
• You have started using alcohol or other substances to cope
• Avoidance behaviors are expanding, and your social world is shrinking
• You are having thoughts of self-harm or suicide

PTSD does not reliably resolve on its own. Follow-up studies show that a substantial proportion of untreated individuals continue to meet diagnostic criteria years later^[3]. The earlier treatment begins, the better the outcome.

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
2. Pitman RK, Rasmusson AM, Koenen KC, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13(11):769-787. DOI · PubMed
3. Department of Veterans Affairs & Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Version 4.0. 2023. DOI · PubMed
4. Hoppen TH, Lindemann L, Halligan SL, et al. The efficacy of psychological interventions for adult post-traumatic stress disorder following exposure to single versus multiple traumatic events: a meta-analysis of randomised controlled trials. Lancet Psychiatry. 2024;11(2):112-122. DOI · PubMed
5. Hoskins MD, Bridges J, Sinnerton R, et al. Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches. Eur J Psychotraumatol. 2021;12(1):1802920. DOI · PubMed
6. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61(8):928-934. DOI · PubMed
7. Karris BC, Thomason AR, Osborne J, et al. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment of post-traumatic stress disorder. Brain Stimul. 2018;11(5):1155-1157. DOI · PubMed
8. Prins A, Bovin MJ, Smolenski DJ, et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med. 2016;31(10):1206-1211. DOI · PubMed